ДУ "Інститут урології
імені академіка О.Ф.Возіанова"

From new imaging technologies, managing high risk prostate cancer (PCa) to the challenges posed by new drugs that present alternatives to standard treatment regimens, PCa experts today examined the various ways on how to offer optimal diagnostics and therapy to patients, particularly those with recurring disease.

---

The Andrology Update 2016 during Thematic Session 5 exclusively featured state-of-the-art lectures including one that highlighted erectile dysfunction (ED) treatment after radical prostatectomy (RP) and how to choose the right method for the right patient.

---

Webcast by M. Emberton, London (GB)
TOOKAD SolubleTM versus active surveillance in men with low risk prostate cancer - a randomized phase 3 clinical trial

Webcast by A.J. Figueiredo, Coimbra (PT)
Laparoscopic living donor nephrectomy: Safety issues. How to best secure the pedicle?

Experts clarified issues on stone diagnosis, prevention and treatment and the recurring message among the speakers was the tendency of urologists to lump together patients in one category despite the subtle -and yet crucial- differences in their disease and individual needs.

---

• Ageing and the lower urinary tract Plenary Session - eURO Auditorium, 07:30 - 10:55 (Hall C1, Level 0)
• Expert challenges expert Thematic Session - Room Paris, 10:30 - 12:00 (Hall B2, level 0)
• Questions in early diagnosis of prostate cancer Thematic Session - Room 1, 10:30 - 12:00 (ICM, Level 0)

---

All webcasts, videos, posters and full-text abstracts are accessible via the EAU16 Resource Centre. Delegates have full access. If you are not attending EAU16, you can purchase access to the EAU16 content separately.